» Articles » PMID: 26336827

MiR-497 Suppresses Angiogenesis and Metastasis of Hepatocellular Carcinoma by Inhibiting VEGFA and AEG-1

Overview
Journal Oncotarget
Specialty Oncology
Date 2015 Sep 5
PMID 26336827
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatocellular carcinoma (HCC) is a worldwide malignance and displays marked vascular abnormalities and active metastasis. MicroRNAs (miRNAs) have been shown to play important roles in regulating tumor properties in cancer, however, whether miR-497 contributes to HCC angiogenesis or metastasis remains unclear. In this study, we found that miR-497 was significantly down-regulated in HCC tissue samples and cell lines. Gain-of-function and loss-of-function studies revealed that miR-497 could repress both the pro-angiogenic and metastatic ability of HCC cells. Subsequent investigations disclosed that miR-497 directly inhibited the 3'-untranslated regions (UTRs) of vascular endothelial growth factor A (VEGFA) and astrocyte elevated gene-1 (AEG-1). Furthermore, overexpression of these targets antagonized the function of miR-497. Based on nude mouse models, we demonstrated that overexpression of miR-497 significantly repressed microvessel densities in xenograft tumors and reduced pulmonary metastasis. In conclusion, our findings indicate that miR-497 downregulation contributes to angiogenesis and metastasis in HCC.

Citing Articles

Deciphering the multifaceted role of microRNAs in hepatocellular carcinoma: Integrating literature review and bioinformatics analysis for therapeutic insights.

Rahdan F, Saberi A, Saraygord-Afshari N, Hadizadeh M, Fayeghi T, Ghanbari E Heliyon. 2024; 10(20):e39489.

PMID: 39498055 PMC: 11532857. DOI: 10.1016/j.heliyon.2024.e39489.


MicroRNA as Key Players in Hepatocellular Carcinoma: Insights into Their Role in Metastasis.

Saadh M, Hussain Q, Alazzawi T, Fahdil A, Athab Z, Yarmukhamedov B Biochem Genet. 2024; .

PMID: 39103713 DOI: 10.1007/s10528-024-10897-0.


A Meta-Analysis of MiRNA-497 and Prognosis of Hepatocellular Carcinoma.

Xie Z, Hao Q, Zhu R, Ma R Can J Gastroenterol Hepatol. 2024; 2024:2211179.

PMID: 38529202 PMC: 10963114. DOI: 10.1155/2024/2211179.


Clinical significance of exosomal noncoding RNAs in hepatocellular carcinoma: a narrative review.

Yoo J, Kang M J Yeungnam Med Sci. 2024; 42:4.

PMID: 38325815 PMC: 11812098. DOI: 10.12701/jyms.2023.01186.


Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies.

Pathak A, Pal A, Roy S, Nandave M, Jain K Stem Cells Int. 2024; 2024:9077926.

PMID: 38213742 PMC: 10783989. DOI: 10.1155/2024/9077926.


References
1.
Maluccio M, Covey A . Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012; 62(6):394-9. DOI: 10.3322/caac.21161. View

2.
Wang Y, Liu I, Chiang C, Wu H . Astrocyte elevated gene-1 is associated with metastasis in head and neck squamous cell carcinoma through p65 phosphorylation and upregulation of MMP1. Mol Cancer. 2013; 12(1):109. PMC: 3856534. DOI: 10.1186/1476-4598-12-109. View

3.
Miura H, Miyazaki T, Kuroda M, Oka T, Machinami R, Kodama T . Increased expression of vascular endothelial growth factor in human hepatocellular carcinoma. J Hepatol. 1998; 27(5):854-61. DOI: 10.1016/s0168-8278(97)80323-6. View

4.
Mac Gabhann F, Popel A . Systems biology of vascular endothelial growth factors. Microcirculation. 2008; 15(8):715-38. PMC: 2722038. DOI: 10.1080/10739680802095964. View

5.
Wang W, Ren F, Wu Q, Jiang D, Li H, Shi H . MicroRNA-497 suppresses angiogenesis by targeting vascular endothelial growth factor A through the PI3K/AKT and MAPK/ERK pathways in ovarian cancer. Oncol Rep. 2014; 32(5):2127-33. DOI: 10.3892/or.2014.3439. View